Logo image of SNYR

SYNERGY CHC CORP (SNYR) Stock Fundamental Analysis

USA - NASDAQ:SNYR - US87165D2080 - Common Stock

2.5 USD
+0.06 (+2.46%)
Last: 10/1/2025, 9:32:37 PM
Fundamental Rating

4

Overall SNYR gets a fundamental rating of 4 out of 10. We evaluated SNYR against 36 industry peers in the Personal Care Products industry. While SNYR is still in line with the averages on profitability rating, there are concerns on its financial health. SNYR scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SNYR had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: SNYR reported negative net income in multiple years.
In multiple years SNYR reported negative operating cash flow during the last 5 years.
SNYR Yearly Net Income VS EBIT VS OCF VS FCFSNYR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2023 2024 0 5M -5M 10M

1.2 Ratios

The Return On Assets of SNYR (13.57%) is better than 88.89% of its industry peers.
SNYR has a Return On Invested Capital of 37.12%. This is amongst the best in the industry. SNYR outperforms 97.22% of its industry peers.
Industry RankSector Rank
ROA 13.57%
ROE N/A
ROIC 37.12%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNYR Yearly ROA, ROE, ROICSNYR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

Looking at the Profit Margin, with a value of 6.10%, SNYR is in the better half of the industry, outperforming 69.44% of the companies in the same industry.
SNYR's Operating Margin of 16.65% is amongst the best of the industry. SNYR outperforms 86.11% of its industry peers.
In the last couple of years the Operating Margin of SNYR has grown nicely.
SNYR has a Gross Margin of 67.87%. This is comparable to the rest of the industry: SNYR outperforms 58.33% of its industry peers.
In the last couple of years the Gross Margin of SNYR has remained more or less at the same level.
Industry RankSector Rank
OM 16.65%
PM (TTM) 6.1%
GM 67.87%
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
SNYR Yearly Profit, Operating, Gross MarginsSNYR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2023 2024 0 20 -20 40 -40 60

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNYR is creating value.
Compared to 1 year ago, SNYR has more shares outstanding
Compared to 5 years ago, SNYR has more shares outstanding
Compared to 1 year ago, SNYR has an improved debt to assets ratio.
SNYR Yearly Shares OutstandingSNYR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2023 2024 20M 40M 60M 80M
SNYR Yearly Total Debt VS Total AssetsSNYR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 0.68, we must say that SNYR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.68, SNYR is doing worse than 69.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACC3.72
WACC9.99%
SNYR Yearly LT Debt VS Equity VS FCFSNYR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 1.91 indicates that SNYR should not have too much problems paying its short term obligations.
SNYR's Current ratio of 1.91 is in line compared to the rest of the industry. SNYR outperforms 52.78% of its industry peers.
SNYR has a Quick Ratio of 1.62. This is a normal value and indicates that SNYR is financially healthy and should not expect problems in meeting its short term obligations.
SNYR's Quick ratio of 1.62 is fine compared to the rest of the industry. SNYR outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.62
SNYR Yearly Current Assets VS Current LiabilitesSNYR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

SNYR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.60%.
Looking at the last year, SNYR shows a very negative growth in Revenue. The Revenue has decreased by -18.57% in the last year.
Measured over the past years, SNYR shows a small growth in Revenue. The Revenue has been growing by 3.48% on average per year.
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SNYR will show a very strong growth in Earnings Per Share. The EPS will grow by 41.50% on average per year.
Based on estimates for the next years, SNYR will show a very strong growth in Revenue. The Revenue will grow by 20.94% on average per year.
EPS Next Y13.89%
EPS Next 2Y11.8%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue Next Year23.04%
Revenue Next 2Y25.98%
Revenue Next 3Y20.94%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNYR Yearly Revenue VS EstimatesSNYR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2023 2024 2025 2026 2027 20M 40M 60M
SNYR Yearly EPS VS EstimatesSNYR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.93, which indicates a very decent valuation of SNYR.
Compared to the rest of the industry, the Price/Earnings ratio of SNYR indicates a rather cheap valuation: SNYR is cheaper than 94.44% of the companies listed in the same industry.
SNYR is valuated cheaply when we compare the Price/Earnings ratio to 27.79, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 5.45, the valuation of SNYR can be described as very cheap.
Based on the Price/Forward Earnings ratio, SNYR is valued cheaply inside the industry as 97.22% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.21. SNYR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.93
Fwd PE 5.45
SNYR Price Earnings VS Forward Price EarningsSNYR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNYR is valued a bit cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.62
SNYR Per share dataSNYR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

SNYR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SNYR's earnings are expected to grow with 41.50% in the coming years.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y11.8%
EPS Next 3Y41.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNYR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SYNERGY CHC CORP

NASDAQ:SNYR (10/1/2025, 9:32:37 PM)

2.5

+0.06 (+2.46%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)12-04 2025-12-04
Inst Owners3.82%
Inst Owner ChangeN/A
Ins Owners7%
Ins Owner Change0.02%
Market Cap27.98M
Analysts82.86
Price Target10.2 (308%)
Short Float %3.13%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.07%
Min EPS beat(2)-90.2%
Max EPS beat(2)40.06%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.9%
Min Revenue beat(2)-11.25%
Max Revenue beat(2)-4.54%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.22%
Valuation
Industry RankSector Rank
PE 8.93
Fwd PE 5.45
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 8.62
EPS(TTM)0.28
EY11.2%
EPS(NY)0.46
Fwd EY18.36%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.11
BVpS-1.4
TBVpS-1.42
PEG (NY)0.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.57%
ROE N/A
ROCE 76.43%
ROIC 37.12%
ROICexc 37.71%
ROICexgc 38.5%
OM 16.65%
PM (TTM) 6.1%
GM 67.87%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
F-ScoreN/A
Asset Turnover2.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.72
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.62
Altman-Z 0.68
F-ScoreN/A
WACC9.99%
ROIC/WACC3.72
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y13.89%
EPS Next 2Y11.8%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%N/A
Revenue Next Year23.04%
Revenue Next 2Y25.98%
Revenue Next 3Y20.94%
Revenue Next 5YN/A
EBIT growth 1Y-46.32%
EBIT growth 3YN/A
EBIT growth 5Y26.96%
EBIT Next Year68.78%
EBIT Next 3Y35.04%
EBIT Next 5YN/A
FCF growth 1Y-1239.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1239.06%
OCF growth 3YN/A
OCF growth 5YN/A